U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
Open in BitSocialBitSocial — the social app with no off switch